DATE |
HEADLINE |
SUMMARY |
June 23, 2021 |
Precision medicine becomes more accessible for Australians with cancer |
A new resource developed at the Garvan Institute of Medical Research and The Kinghorn Cancer Centre for oncologists could help make targeted cancer therapies more accessible for Australian patients. The TOPOGRAPH (Therapy-Oriented Precision Oncology Guidelines for Recommending Anti-cancer Pharmaceuticals) database is an online tool that catalogues oncology research to streamline the process of recommending therapeutic treatments in precision cancer medicine. link |
June 3, 2021 |
Gene Behind Childhood Bone Cancer Uncovered |
Researchers based at the University of North Carolina at Chapel Hill have discovered that the gene OTUD7A controls a cancer-causing protein in Ewing sarcoma, a type of bone cancer mostly impacting children. link |
April 21, 2021 |
Messenger RNA Vaccines: Beckoning of a New Era in Cancer Immunotherapy |
Messenger RNA (mRNA) vaccines are a relatively new class of vaccines. They combine the potential of mRNA to encode for almost any protein with an excellent safety profile and a flexible production process. Recently, 2 mRNA vaccines were approved for the first time for human use – to prevent COVID-19 infection – bringing excitement for the future possibilities of this approach for cancer immunotherapy as well as for preventing other infectious diseases. link |
March 30, 2021 |
FDA grants fast track designation to annamycin for sarcoma lung metastases |
The FDA granted fast track designation to annamycin for the treatment of patients with lung metastases from soft tissue sarcoma, according to a press release from the agent’s manufacturer. link |